ObsEva ^{Priced, Nasdaq: OBSV}

We are focused on providing therapeutic solutions for women between the ages of 15 and 49 who suffer from reproductive health conditions that affect their quality of life, ability to conceive or that complicate pregnancy and the health of newborns. There are millions of women of reproductive age affected by conditions such as endometriosis, uterine fibroids and preterm labor, or that require in vitro fertilization, or IVF, to conceive. Our most advanced product candidates are designed to address the symptoms associated with endometriosis and uterine fibroids and to improve clinical pregnancy and live birth rates in women undergoing IVF. Endometriosis is an often painful disorder in which tissue that normally lines the inside of the uterus, called the endometrium, grows outside of the uterus, causing monthly bleeding and chronic inflammatory reactions inside the abdomen, that may result in ovarian cyst formation, scar tissue and adhesions. Uterine fibroids, also known as leiomyomata or myoma, are common non-cancerous tumors that develop in the muscular wall of the uterus and have disabling symptoms such as heavy menstrual bleeding. We are also developing a product candidate to treat preterm labor.